Enhancing machine learning‐based binder design with high‐throughput screening: A comparison of mRNA and yeast display technologies
Protein Science · 2026
DOI: 10.1002/pro.70696 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Protein Science, 2026. Verfasst von Zhiyuan Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Machine Learning, RNA, Messenger, Saccharomyces cerevisiae, High-Throughput Screening Assays. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Recent advances in machine learning (ML)‐based protein design methods have enabled the rapid in silico generation of large libraries of miniprotein binders with minimal manual input. While computational design capacity has scaled rapidly, experimental validation methods have lagged, creating a bottleneck in binder discovery pipelines. Here, we apply mRNA display to screen an ML‐designed miniprotein binder library and directly compare its performance with the more widely used yeast surface display platform using a single shared DNA library. We screened 2009 designs targeting the platelet receptor TLT‐1 and 3159 designs targeting the immune receptor B7‐H3 across both platforms. While both selection protocols reliably identified functional binders, we found that mRNA display preferentially enriched binders with slower dissociation rates. In addition, mRNA display achieved higher library coverage than yeast display, likely rescuing functional designs that are penalized in a cell‐based expression system. Biophysical characterization of selected binders from both platforms revealed strong binding affinities and high thermal stabilities. These results showcase the power of integrating ML‐based computational design tools with rapid in vitro selection technologies, providing a scalable framework for therapeutic miniprotein discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
- Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
- Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
ORCID-Profile: Zhiyuan Yao, Brian Kuhlman
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Yao, Z., Metts, M., Huber, A. K., Li, J., Kinjo, T., Dieckhaus, H., Nallathambi, A., Bowers, A. A., & Kuhlman, B. (2026). Enhancing machine learning‐based binder design with high‐throughput screening: A comparison of mRNA and yeast display technologies. Protein Science. https://doi.org/10.1002/pro.70696
Vancouver
Yao Z, Metts M, Huber AK, Li J, Kinjo T, Dieckhaus H, et al. Enhancing machine learning‐based binder design with high‐throughput screening: A comparison of mRNA and yeast display technologies. Protein Science. 2026. doi:10.1002/pro.70696
BibTeX
@article{Yao2026,
author = {Yao, Zhiyuan and Metts, McGuire and Huber, Avery K and Li, Jingjing and Kinjo, Tomoaki and Dieckhaus, Henry and Nallathambi, Amrita and Bowers, Albert A and Kuhlman, Brian},
title = {Enhancing machine learning‐based binder design with high‐throughput screening: A comparison of mRNA and yeast display technologies},
journal = {Protein Science},
year = {2026},
doi = {10.1002/pro.70696}
}
EUVIMED